These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38336251)

  • 1. Safety, tolerability, pharmacokinetics and neutrophil elastase inhibitory effects of Sivelestat: A randomized, double-blind, placebo-controlled single- and multiple-dose escalation study in Chinese healthy subjects.
    Li K; Dong L; Gao S; Zhang J; Feng Y; Gu L; Yang J; Liu X; Wang Y; Mao Z; Jiang D; Xia Z; Zhang G; Tang J; Ma P; Zhang W
    Eur J Pharm Sci; 2024 Apr; 195():106723. PubMed ID: 38336251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study.
    Zeiher BG; Artigas A; Vincent JL; Dmitrienko A; Jackson K; Thompson BT; Bernard G;
    Crit Care Med; 2004 Aug; 32(8):1695-702. PubMed ID: 15286546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study.
    Yuan G; Chen Y; Li L; Wang X; Wei G; Zeng J; Hui AM; Jiang Y; Zhao H; Diao L; Zhou Y; Xiao Y; Chen M
    Int J Clin Pract; 2024; 2024():1386980. PubMed ID: 38481823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects.
    Liu X; Xue L; Zhang H; Xu Q; Zhang S; Ma S; Ding X; Liu L; Dong J; Qian L; Xia W; Jiang K; Huang C; Miao L
    Clin Drug Investig; 2020 Jun; 40(6):555-566. PubMed ID: 32277364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the neutrophil elastase inhibitor sivelestat on perioperative inflammatory response after pediatric heart surgery with cardiopulmonary bypass: a prospective randomized study.
    Kohira S; Oka N; Inoue N; Itatani K; Hanayama N; Kitamura T; Fujii M; Takeda A; Oshima H; Tojo K; Yoshitake S; Miyaji K
    Artif Organs; 2013 Dec; 37(12):1027-33. PubMed ID: 23834653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Anti-IFNAR1 Monoclonal Antibody QX006N: A First-in-Human Single Ascending Dose Study in Healthy Chinese Volunteers.
    Li X; Li B; Wang M; Fang M; Lou J; Liu J; Chen H; Ding Y
    BioDrugs; 2024 Mar; 38(2):313-321. PubMed ID: 38148466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability and Pharmacokinetics of Single Escalating and Repeated Doses of CN-105 in Healthy Participants.
    Li S; Wangqin R; Meng X; Li H; Wang Y; Wang H; Laskowitz D; Chen X; Wang Y
    Clin Ther; 2022 May; 44(5):744-754. PubMed ID: 35562205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of a selective neutrophil elastase inhibitor (sivelestat) on lipopolysaccharide-induced acute dysfunction of the pulmonary microcirculation.
    Inoue Y; Seiyama A; Tanaka H; Ukai I; Akimau P; Nishino M; Shimazu T; Sugimoto H
    Crit Care Med; 2005 Aug; 33(8):1814-22. PubMed ID: 16096460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double-blinded, placebo-controlled phase I study of the pharmacokinetics, pharmacodynamics, and safety of KL130008, a novel oral JAK inhibitor, in healthy subjects.
    Li N; Du S; Wang Y; Zhu X; Shu S; Men Y; He M; Fang F; Wang Y; Gong Y; Chen J; Gu L; Cheng Y; He Q; Lu H; Niu Y; Xu Y; Feng P
    Eur J Pharm Sci; 2022 Sep; 176():106257. PubMed ID: 35820629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study.
    Chu NN; Huang K; Que LL; Ding Y; Gu XH; Zhang L; Wang JK; Chen XP; Sun ZG; He Q
    Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):509-521. PubMed ID: 35429285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design.
    Wu M; Li C; Zhang H; Sun J; Zhu X; Li X; Gao X; Wang W; Ding Y
    CNS Drugs; 2020 Aug; 34(8):867-877. PubMed ID: 32700191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I Dose-Escalation Study of The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Polyethylene Glycol-Erythropoietin (PEG-EPO) in Healthy Subjects.
    Hu C; Sun W; Wu Y; Huang J; Zhang X; Zhang L
    Clin Ther; 2024 Aug; 46(8):636-643. PubMed ID: 39117488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.
    Chen GL; Liu Y; Gao XF; Wu KQ; Yang YK; Chen Y; Peng CG; Jin TH; Huang YB; Zhang YW; Su J; Jiang Q; Guo T; Zhao J; Peng XN; Peng JY; Li SX; Sun YL; Zhang HM; Fu YL; Luo D; Ma Y; Shen ZW; Zhang YT; Shou ZF
    Diabetes Obes Metab; 2024 Apr; 26(4):1395-1406. PubMed ID: 38287130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, Pharmacokinetics and Pharmacodynamics of TNHH, a Novel Targeted Neutrophil-Inhibitory Hirulog Hybrid Glycoprotein, in Healthy Volunteers.
    Gou ZP; Song ZH; Chen XG; Hu XC; Wang Y; Fan K; Cai YM; Zheng L
    CNS Drugs; 2019 Jun; 33(6):605-614. PubMed ID: 31093952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial.
    Li X; Liu Y; Yao H; Wang M; Gao L; Lou J; Mao J; Wu W; Zhou Y; Tang Y; Yan W; Hu Y; Ding C; Chen S; Niu J; Ding Y
    Antimicrob Agents Chemother; 2022 May; 66(5):e0009422. PubMed ID: 35404074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, Tolerability, Pharmacokinetics and Quantitative Electroencephalography Assessment of ACD856, a Novel Positive Allosteric Modulator of Trk-Receptors Following Multiple Doses in Healthy Subjects.
    Önnestam K; Nilsson B; Rother M; Rein-Hedin E; Bylund J; Anderer P; Kemethofer M; Halldin MM; Sandin J; Segerdahl M
    J Prev Alzheimers Dis; 2023; 10(4):778-789. PubMed ID: 37874100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study.
    Xu J; Zhang H; Chen H; Zhu X; Jia H; Xu Z; Huo D; Zhang H; Li C; Ding Y
    Ann Med; 2023; 55(2):2264850. PubMed ID: 38071661
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652, a Reversible Fatty Acid Amide Hydrolase Inhibitor, in Healthy, Nonelderly, Japanese Men and Elderly, Japanese Men and Women: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Phase I Study.
    Takizawa M; Hatta T; Iitsuka H; Katashima M; Sato Y; Kuroishi K; Nagashima H
    Clin Ther; 2020 May; 42(5):906-923. PubMed ID: 32456804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tolerability of intravenous ibuprofen injection in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study
.
    Zhou H; Xu W; Wu G; Wu L; Shentu J; Pan Z; Hu S; Liu Y
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):904-913. PubMed ID: 27569737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, Safety Profile, and Tolerability of Tetramethylpyrazine Nitrone Tablets After Single and Multiple Ascending Doses in Healthy Chinese Volunteers.
    Zhu G; Wang L; Zhong S; Han S; Peng H; Tong M; He X
    Eur J Drug Metab Pharmacokinet; 2024 Mar; 49(2):207-217. PubMed ID: 38381348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.